Guardant Health’s stock up after FDA approves its blood test for colon-cancer screening
It’s the first such blood test to receive regulatory approval in the U.S. and the first that meets the requirements for Medicare coverage.
It’s the first such blood test to receive regulatory approval in the U.S. and the first that meets the requirements for Medicare coverage.
